References
- Organisation Mondiale de la Santé. Guide de prise en charge de la tuberculose. Kinshasa. 2008. Google Scholar
- Organisation Mondiale de la Santé. Plan mondial halte à la tuberculose 2011-2015. Geneva. 2010. Google Scholar
- Organisation Mondiale de la Santé. Rapport sur la lutte contre la tuberculose dans le monde. Geneva. 2011. Google Scholar
- Organisation Mondiale de la Santé. Rapport sur la santé dans le monde. Geneva. 1997. Google Scholar
- Ministère de la Santé. Plan stratégique 2006-201 Programme National de Lutte contre la Tuberculose. Kinshasa. 2006. Google Scholar
- Ministère de la Santé. Enquête de prévalence sur la résistance tuberculeuse dans la ville de Kinshasa. Programme National de Lutte contre la Tuberculose. Kinshasa, 1999. Google Scholar
- Organisation Mondiale de la Santé. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva. 2008. Google Scholar
- Caminero JA. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding (State of the art series, Drug-resistant tuberculosis, Edited by CY, Chiang, Number 4 in the series). Int J Tuberc Lung Dis. 2010; 14(4): 382-390. PubMed | Google Scholar
- Organisation Mondiale de la Santé. Interim recommendations
for the surveillance of drug resistance in tuberculosis. Geneva. 2007. Google
Scholar
- Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis. 2002; 6(10): 858-864. PubMed | Google Scholar
- Organisation Mondiale de la Santé. Global Tuberculosis Control- surveillance, planning, financing. Geneva. 2008. Google Scholar
- Organisation Mondiale de la Santé. The Global MDR-TB and XDR-TB Response Plan 2007-2008. Geneva. 2007. Google Scholar
- Organisation Mondiale de la Santé (2006). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs -worldwide, 2000-2004. Morb Mortal Wkly Rep. 2006; 55(11): 301-305. PubMed | Google Scholar
- Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. The Lancet. 2006; 368 (9547): 1575-1580. PubMed | Google Scholar
- Kim JY, Mukherjee JS, Rich ML, Mate K, Bayona J, Becerra MC. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Tuberculosis. 2003; 83(13): 59-65. PubMed | Google Scholar
- Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis (State of the art series, Drug-resistant tuberculosis, Edited by CY; Chiang; Number 1 in the series). Int J TubercLung Dis. 2009; 13(11): 1320-1330. PubMed | Google Scholar
- Organisation Mondiale de la Santé. Anti-tuberculosis drug resistance in the World. Geneva. 2008. Google Scholar
- Marahatta SB, Kaewkungwal J, Ramasoota P, Singhasivanon P. Risk factors of Multidrug Resistant Tuberculosis in central Nepal: A pilot study. Kathmandu Univ Med J. 2012; 8(4): 392-397. PubMed | Google Scholar
- Ahmad AM, Akhtar S, Hasan R, Khan JA, Hussain SF, Rizvi N. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study. Int J Mycobacteriol. 2012; 1(3): 137-142. PubMed | Google Scholar
- Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rüsch-Gerdes S, Gutiérrez J, Jarlier V. A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist. 2005; 11(1): 62-67. PubMed | Google Scholar
- Skrahina A, Hurevich H, Zalutskaya A, Sahalchyk E, Astrauko A, Hoffner S, Rusovich V, Dadu A, De Colombani P, Dara M, Van Gemert W, Zignol M. Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors. Bull World Health Organ. 2013; 91(1): 36-45. PubMed | Google Scholar
- Suárez-García I, Rodríguez-Blanco A, Vidal-Pérez JL, García-Viejo MA, Jaras-Hernández MJ, López O, Noguerado-Asensio A. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis. 2009; 28(4): 325-330. PubMed | Google Scholar
- Law WS, Yew WW, Chiu Leung C, Kam KM, Tam CM, Chan CK, Leung CC. Risk factors for multidrug-resistant tuberculosis in Hong Kong. IntJ Tuberc Lung Dis. 2008; 12(9): 1065-1070. PubMed | Google Scholar
- Organisation Mondiale de la Santé. Standards Internationaux pour le traitement de la tuberculose : Diagnostic, Traitement et Santé Publique. Geneva. 2006. Google Scholar
- Dabis F, Drucker J, Moren A. Épidémiologie d'intervention: aspects particuliers de la pratique de l'épidémiologie. Notes de cours ; Université Bordeaux Segalen. 2009. Google Scholar
- Bercion R, Kuaban C, Bercion R, Kuaban C. Résistance Initiale aux antituberculeux à Yaoundé, Cameroun, en 1995. Int J Tuberc Lung Dis. 1997; 1(2): 110-114. PubMed | Google Scholar
- Organisation Mondiale de la Santé. Principes directeurs à l'intention des programmes antituberculeux pour la prise en charge des tuberculoses pharmaco résistantes. Geneva. 2008. Google Scholar